4-5689175-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_147127.5(EVC2):​c.688A>G​(p.Ser230Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.225 in 1,613,956 control chromosomes in the GnomAD database, including 41,951 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S230R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.22 ( 3753 hom., cov: 33)
Exomes 𝑓: 0.23 ( 38198 hom. )

Consequence

EVC2
NM_147127.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.22

Publications

33 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, Myriad Women's Health, Laboratory for Molecular Medicine

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_147127.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004810661).
BP6
Variant 4-5689175-T-C is Benign according to our data. Variant chr4-5689175-T-C is described in ClinVar as Benign. ClinVar VariationId is 262620.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.371 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147127.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
NM_147127.5
MANE Select
c.688A>Gp.Ser230Gly
missense
Exon 5 of 22NP_667338.3
EVC2
NM_001166136.2
c.448A>Gp.Ser150Gly
missense
Exon 5 of 22NP_001159608.1Q86UK5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
ENST00000344408.10
TSL:1 MANE Select
c.688A>Gp.Ser230Gly
missense
Exon 5 of 22ENSP00000342144.5Q86UK5-1
EVC2
ENST00000310917.6
TSL:1
c.448A>Gp.Ser150Gly
missense
Exon 5 of 22ENSP00000311683.2Q86UK5-2
EVC2
ENST00000475313.5
TSL:1
n.448A>G
non_coding_transcript_exon
Exon 5 of 23ENSP00000431981.1A0A0C4DGE7

Frequencies

GnomAD3 genomes
AF:
0.221
AC:
33675
AN:
152042
Hom.:
3746
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.196
Gnomad AMI
AF:
0.139
Gnomad AMR
AF:
0.238
Gnomad ASJ
AF:
0.231
Gnomad EAS
AF:
0.385
Gnomad SAS
AF:
0.274
Gnomad FIN
AF:
0.229
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.217
Gnomad OTH
AF:
0.236
GnomAD2 exomes
AF:
0.239
AC:
60173
AN:
251426
AF XY:
0.241
show subpopulations
Gnomad AFR exome
AF:
0.196
Gnomad AMR exome
AF:
0.252
Gnomad ASJ exome
AF:
0.220
Gnomad EAS exome
AF:
0.398
Gnomad FIN exome
AF:
0.231
Gnomad NFE exome
AF:
0.214
Gnomad OTH exome
AF:
0.234
GnomAD4 exome
AF:
0.226
AC:
330040
AN:
1461796
Hom.:
38198
Cov.:
33
AF XY:
0.227
AC XY:
164757
AN XY:
727188
show subpopulations
African (AFR)
AF:
0.188
AC:
6279
AN:
33478
American (AMR)
AF:
0.250
AC:
11188
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.224
AC:
5855
AN:
26132
East Asian (EAS)
AF:
0.347
AC:
13789
AN:
39696
South Asian (SAS)
AF:
0.258
AC:
22212
AN:
86258
European-Finnish (FIN)
AF:
0.227
AC:
12118
AN:
53394
Middle Eastern (MID)
AF:
0.215
AC:
1242
AN:
5768
European-Non Finnish (NFE)
AF:
0.219
AC:
243532
AN:
1111960
Other (OTH)
AF:
0.229
AC:
13825
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
15542
31084
46625
62167
77709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8608
17216
25824
34432
43040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.221
AC:
33693
AN:
152160
Hom.:
3753
Cov.:
33
AF XY:
0.225
AC XY:
16703
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.196
AC:
8124
AN:
41522
American (AMR)
AF:
0.238
AC:
3640
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.231
AC:
803
AN:
3470
East Asian (EAS)
AF:
0.386
AC:
1992
AN:
5166
South Asian (SAS)
AF:
0.273
AC:
1313
AN:
4818
European-Finnish (FIN)
AF:
0.229
AC:
2421
AN:
10582
Middle Eastern (MID)
AF:
0.204
AC:
60
AN:
294
European-Non Finnish (NFE)
AF:
0.217
AC:
14725
AN:
67994
Other (OTH)
AF:
0.232
AC:
489
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1396
2791
4187
5582
6978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
372
744
1116
1488
1860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.220
Hom.:
17222
Bravo
AF:
0.222
Asia WGS
AF:
0.302
AC:
1047
AN:
3478
EpiCase
AF:
0.221
EpiControl
AF:
0.222

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Ellis-van Creveld syndrome (2)
-
-
2
not specified (2)
-
-
1
Curry-Hall syndrome (1)
-
-
1
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
15
DANN
Benign
0.80
DEOGEN2
Benign
0.051
T
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.80
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.61
T
MetaRNN
Benign
0.0048
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.2
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.94
N
REVEL
Benign
0.099
Sift
Benign
0.13
T
Sift4G
Uncertain
0.025
D
Varity_R
0.067
gMVP
0.47
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4689278;
hg19: chr4-5690902;
COSMIC: COSV60389850;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.